Application of 21-Gene test in adjuvant radiotherapy for early breast cancer
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 3
Abstract
Breast cancer is the most common malignant tumor in women. With the development of genomics technology and medical frontier technology, the systemic treatment of breast cancer has gradually entered the era of personalized medicine. However, the decision-making of adjuvant radiotherapy for breast cancer still mainly relies on traditional clinicopathological factors, and there is a lack of scientific and reliable tools to guide precise radiotherapy in different populations. Hormone receptor (HR) positive/human epidermal growth factor receptor 2 (HER2) negative breast cancer is the most common molecular subtype of breast cancer. The 21-Gene recurrence score (RS) test (Oncotype Dx™, Genomic Health, Redwood City, CA) is a commercially available genomic test for breast cancer. In this article, we reviewed the current research evidence on the use of 21-Gene RS test for radiotherapy decision-making in HR-positive HER2-negative early breast cancer. Current clinical studies support the predictive value of 21-Gene RS test for adjuvant radiotherapy, and several large-scale prospective clinical studies in this area are underway.
Authors and Affiliations
Xiaolu TANG, Xin HUA, Lu CAO, Jiayi CHEN
Keywords
Related Articles
- EP ID EP750976
- DOI 10.16139/j.1007-9610.2024.03.15
- Views 11
- Downloads 0
The current status of thermal ablation in the treatment of papillary thyroid microcarcinoma
Thermal ablations are rapidly developing techniques for minimally invasive treatment, including laser ablation, radiofrequency ablation, and microwave ablation. Such remarkable success has been achieved in treatment mali...
Current status of minimally invasive surgery of gastroesophageal reflux disease
Gastroesophageal reflux disease (GERD) is one of the common gastrointestinal diseases. The treatment options for GERD includes lifestyle changes, medication, and surgery. With the development of surgical technology, mini...
Value of contrast-enhanced ultrasound in differentiating benign and malignant gallbladder lesions which diameter more than 1 cm
[Objective] To investigate the clinical value of contrast-enhanced ultrasound (CEUS) in differential diagnosis between benign and malignant gallbladder lesions which diameter more than 1 cm. [Methods] A retrospective a...
Pheochromocytoma with papillary thyroid carcinoma: one case report
Pheochromocytoma is one of rare tumors of neuroendocrine. Most of the tumors are sporadic with about 1/3 of them caused by genetic mutations. Papillary thyroid carcinoma (PTC) from thyroid follicular cells is the most co...
Propensity score matching method evaluate the clinical efficacy of comprehensive treatment for synchronous primary advanced gastric and esophageal cancer
[Objective] To evaluate the clinical efficacy of comprehensive treatment for synchronous primary advanced gastric and esophageal cancer by propensity score matching (PSM). [Methods] A total of 2 551 patients with adv...